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Abstract Evidence is presented that lactoferrin (LF), an Fe3+-
binding glycoprotein, possesses two DNA-binding sites with
different affinities for specific oligonucleotides (ODNs) (Kd1 =
8 nM; Kd200.1 mM). The high affinity site became labeled after
incubation with affinity probes for DNA-binding sites ; like the
antibacterial and polyanion-binding sites, this site was shown to
be located in the N-terminal domain of LF. Interaction of
heparin with the polyanion-binding site inhibits the binding of
ODNs to both sites. These data suggest that the DNA-binding
sites of LF coincide or overlap with the known polyanion and
antimicrobial domains of the protein.
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1. Introduction
LF, an Fe3-binding glycoprotein, was ¢rst recognized in
milk and then in other human epithelial secretions and barrier
body £uids. LF, a major protein of human milk, is thought to
be responsible for primary defence against microbial infec-
tions. The single polypeptide chain of LF (76 kDa) forms
two lobes [1], each of which ¢xes one Fe3 ion and contains
one glycan chain [2]. In human milk only 15% of LF is satu-
rated by iron.
Thus apo-LF, by removing iron from the surrounding en-
vironment, could prevent bacteria from proliferating [3].
However, LF is known as an extremely polyfunctional pro-
tein, many functions of which appear to be at least in part
independent of its iron-binding activity. LF is a potent acti-
vator of natural killer cells [4] and may play a role in anti-
tumor defence [5], and this activity is independent of iron. LF
also regulates granulopoiesis [6], antibody-dependent cytotox-
icity [4], cytokine production [7,8], and growth of some cells in
vitro [9]. The nature of such functions remains unclear as yet.
On the other hand, some of these functions may be the result
of binding of LF to speci¢c DNA sequences. LF was recently
shown to enter the cell from the surrounding environment and
to be transported into the nucleus where it binds to DNA
[10,11]. Speci¢c DNA sequences that can confer LF-induced
transcription of a reporter gene have now been identi¢ed [10].
Recently an ATP-binding site of LF was revealed [12,13]. In
terms of the polyfunctional activity of LF, the investigation of
its DNA-, polyanion-, ATP- and other possible binding sites
and the relationship between them would be very interesting
and could provide a new approach to understanding the mul-
tiple regulatory properties of this extremely polyfunctional
protein.
In the present article we demonstrate by di¡erent methods
that human milk LF possesses two DNA-binding sites which
interact with speci¢c and non-speci¢c ODNs, at least one of
which is located in the N-domain of the protein. Binding of
polyanions, such as heparin and tRNA, was shown to inhibit
the binding of DNA by LF.
2. Materials and methods
Reagents used in this work were obtained mainly from Merck. We
also used heparin, antibodies to human LF, tRNALys (Sigma),
DEAE-cellulose DE-52 (Whatman), and heparin-Sepharose (Pharma-
cia). Radioisotopes were purchased from Amersham (3000 Ci/mmol).
Electrophoretically and immunologically homogeneous LF was ob-
tained by sequential chromatography of human milk proteins on
DEAE-cellulose, heparin-Sepharose and anti-LF-Sepharose columns
as described previously [12].
Fluorescence was measured in a thermostated (25‡C) cell in a Hi-
tachi MPF-2A spectro£uorimeter. Excitation was at 290 nm and emis-
sion at 335 nm. The reaction mixture contained 20 mM Tris-HCl, pH
7.0, and 0.3 mg/ml LF. Retardation assays were performed by PAGE
in 20% gels using Tris-H3BO3 bu¡er, pH 8.0 [14]. The Kd values were
estimated using non-linear regression analysis [15]; the binding data
were presented as Scatchard plots [16].
A⁄nity labeling of LF was carried out in a 20 Wl reaction mixture
containing 4 WM LF and 5^20 WM 2P,3P-dialdehyde derivatives of the
speci¢c oligonucleotide d(TAGAAGATCAA)rA (oxODN-1) or the
non-speci¢c oligonucleotide d(T)9rU (oxT9U) (prepared by oxidation
of [5P-32P]ODNs with NaIO4 [17]) in 20 mM imidazole bu¡er, pH 7.5.
After incubation for 30 min at 20‡C, 1 Wl of 0.1 mM NaBH4 was
added and the mixture was further incubated for 30 min to reduce
Schi¡’s bases. Covalent binding of [32P]oxODNs by LF was analyzed
by SDS-PAGE and visualized by autoradiography.
Limited cleavage of LF modi¢ed with [32P]oxODNs ([32P]LF) at
Met residues was carried out in a 30 Wl reaction mixture containing
25 mM HCl, 0.1% SDS, 3^5 Wg [32P]LF, and a 50-fold molar excess of
BrCN, for 3^5 min at 20‡C [19]. Partial proteolytic cleavage of
[32P]LF was performed using 0.1^0.5% trypsin (w/w of [32P]LF) in
0.1 M Tris-HCl, pH 8.2, 25 mM CaCl2 at 37‡C for 4 h [18]; both
digests were then boiled for 0.5 min and subjected to SDS-PAGE in
12% gels.
3. Results and discussion
To search for DNA-binding activity of LF, human milk
apo-LF (containing no Fe3 ions) from the fraction non-ad-
sorbed by DEAE-cellulose was puri¢ed by sequential chroma-
tography on heparin-Sepharose and anti-LF-Sepharose col-
umns as described previously [12]. This apo-LF fraction
interacted with various speci¢c and non-speci¢c oligonucleo-
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tides; the addition of d(pT)10 led to a practically complete loss
(vFmax = 95^100%) of the £uorescence emission by the trypto-
phan residues of the LF. The Scatchard plot (Fig. 1A) calcu-
lated from the £uorimetric data was not linear, and two dis-
sociation constants for the LF-d(pT)10 complexes were
estimated: Kd1 = 0.8 þ 0.3 WM and Kd2 = 36 þ 5 WM. A further
approach provided direct evidence that LF possesses two
DNA-binding sites. The Scatchard plot calculated from gel
retardation data (Fig. 1B) showed that LF binds 2 moles of
d(pT)10 per mole of the protein; the calculated Kd values
are 1.5 þ 0.5 WM and 45 þ 7 WM and comparable with the
above Kd values. Similar data were obtained for several other
non-speci¢c d(pN)n : d(pA)10 (Kd1 = 0.5 þ 0.1 WM, Kd2 = 22 þ
3 WM); d(pC)10 (Kd1 = 0.6 þ 0.1 WM, Kd2 = 25 þ 4 WM);
d(CTGTTCCGCCTC) (Kd1 = 0.6 þ 0.1 WM, Kd2 = 32 þ 2 WM).
Both sites of LF interact with single stranded (ss) d(pT)10
and double stranded (ds) d(pT)10Wd(pA)10 (Kd1(ds) = 0.4 þ 0.1
and Kd2(ds) = 20 þ 5 WM). The second d(pA)10 strand in-
creased the a⁄nity for d(pT)10 by a factor of 2^3.
As shown recently [10], LF interacts with DNAs containing
the speci¢c sequence TAGAAGATCAAA (ODN-1) and acti-
vates transcription. Here we have analyzed the interaction of
LF with the speci¢c single and double stranded forms of
ODN-1. The ¢rst site of LF demonstrates a 05^20-fold high-
er a⁄nity for single and double stranded ODN-1
(Kd1(ss) = 0.08 þ 0.02 WM and Kd1(ds) = 0.011 þ 0.002 WM)
than for non-speci¢c d(pN)n and the d(pT)10Wd(pA)10 duplex.
While LF binds the second molecule of d(pN)n with an a⁄n-
ity 30^56 times lower than the ¢rst one, its a⁄nity for the
second molecule of single stranded ODN-1 (Kd2(ss) 0100
WM) is 1250 times lower that that for the ¢rst one.
It is reasonable to believe that lactoferrin possesses two
non-identical DNA-binding sites with di¡ering a⁄nities for
any oligonucleotides. However, the 30^56- and 1250-fold dif-
ferences in Kd2/Kd1 ratios for non-speci¢c d(pN)n and speci¢c
ODN-1 oligonucleotide, respectively, can re£ect either an ini-
tial di¡erence in the DNA-binding a⁄nity for the two DNA
molecules or their antagonistic binding by the protein. In the
absence of cooperative interactions between the two DNA-
binding sites of LF, a similar relative di¡erence of the LF
a⁄nity of each site for di¡erent speci¢c or non-speci¢c oligo-
nucleotides might be expected. The 20^40-fold greater di¡er-
ence between the relative a⁄nities of the ¢rst and the second
DNA-binding sites observed for speci¢c and non-speci¢c oli-
gonucleotides may be indicative of a strong anti-cooperative
binding of two speci¢c DNA molecules by LF. Thus, it is not
unlikely that the initial di¡erence of non-speci¢c d(pN)n oli-
gonucleotide a⁄nities for two DNA-binding sites is attenu-
ated due to anti-cooperative binding of the speci¢c oligonu-
cleotide.
In order to reveal the localization of the DNA-binding sites
of LF, a⁄nity probes for DNA-binding sites were used, the
2P,3P-dialdehyde derivatives of [5P-32P]d(TAGAAGATCA-
A)rA (oxODN-1) and of [5P-32P]d(pT)9r(pU) (oxT9U) (Fig.
2A). LF became labeled after incubation with both a⁄nity
probes at low concentrations (comparable with the Kd1 values
for these oligonucleotides). Since LF demonstrates a large
di¡erence in a⁄nity for the ¢rst and second oligonucleotide
Fig. 1. A Scatchard plot for ss d(pT)10 binding to LF as measured
by £uorescence spectroscopy (A) and gel retardation (B); X is the
number of moles of oligonucleotide bound per mole of protein.
Fig. 2. A: SDS-PAGE of LF in a 12% gel before (lane 1, zero time
of incubation) and after a⁄nity labeling by incubation with 5P-
[32P]oxT9U in di¡erent conditions (lanes 1^5, autoradiographs). LF
was incubated with 5P-[32P]oxT9U (1 WM) in the absence of other li-
gands (lanes 2 and 3) or in the presence of 1 WM ss d(TAGAA-
GATCAAA) (lane 4), or 10 WM d(pT)10 (lane 5). After incubation
with the [32P]probe, the samples were treated with NaBH4 in all
cases except lane 2. B: SDS-PAGE in a 12% gel of LF modi¢ed
with 5P-[32P]oxT9U before (lanes 1 and 4) and after partial cleavage
with trypsin (lanes 2 and 5) or mild cleavage with CNBr (lanes 3
and 6): lanes 1^3, stained with silver; lanes 4^6, autoradiographs.
Arrows indicate the positions of molecular mass markers.
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molecules and the 32P-labeling of LF is observed only after
incubation of the reaction mixtures with NaBH4 to reduce
Schi¡’s bases (Fig. 2A), it is clear that both oxODNs modi¢ed
Lys of the high a⁄nity DNA-binding site. These modi¢ca-
tions met the known criteria of a⁄nity modi¢cation [20] :
di¡erent speci¢c and non-speci¢c oligonucleotides prevented
essentially completely the covalent binding of [5P-32P]oxODNs
(Fig. 2A).
Mild treatment of LF by trypsin at pH 8.2 cleaves the
molecule between Lys283 and Ser284 into N- and C-tryptic
fragments of 30 and 50 kDa, respectively [21]. Partial hydrol-
ysis of [32P]oxODN-labeled LF ([32P]LF) by trypsin led to the
same two polypeptides, but only the 30 kDa polypeptide was
labeled (Fig. 2B, lane 5). Thus, the high a⁄nity DNA-binding
site is located in the N-domain of LF. The same conclusion
may be drawn from the analysis of the products of limited
cleavage of LF with CNBr. Complete CNBr-induced frag-
mentation of LF at Met residues should result in the forma-
tion of six polypeptides of 3.3, 40.0, 8.7, 13.1, 1.0 and 10.0
kDa (NCC direction). After mild treatment of LF only 52,
65, 66, and 73 kDa [32P]polypeptides were obtained. The only
way to explain the formation of these [32P]polypeptides is that
oxT9U modi¢es Lys in the 40.0 kDa polypeptide of the N-
domain. The 052 kDa polypeptide (Fig. 2B) corresponds to
the sum of 40.0 and 8.7 kDa CNBr fragments produced by
cleavage of the C-terminal part of LF, while the 065 kDa
polypeptide consists of the 52 kDa fragment and the C-termi-
nal CNBr fragment of 13.1 kDa and so on: 66 kDa = 65+1
kDa and 73 kDa = 65+10 kDa.
Thus high a⁄nity DNA-binding sites, like the polyanion-
binding and antimicrobial domains which were demonstrated
earlier [22,23], are located near the N-terminus of LF in a
region distinct from its iron-binding site. The question may
be raised whether this site is identical to the well known anti-
microbial and/or polyanion-binding sites. Di¡erent poly-
anionic ligands (RNA, tRNA and heparin) were found to
suppress the binding of the speci¢c [32P]oligonucleotide and
the non-speci¢c [32P]d(pT)10 under conditions where the
ODNs interact with only one or both DNA-binding sites
(Fig. 3). This means that both DNA-binding sites can interact
not only with DNA, but also with other polyanionic ligands
like heparin. Moreover, it is likely that the DNA-binding sites
coincide or at least strongly overlap with the well known
antimicrobial and polyanion-binding sites. Since oligonucleo-
tides interact with apo-LF, one can conclude that the binding
of LF with DNA is iron independent.
Recently we have demonstrated that in addition to the
above mentioned functions human milk LF binds ATP with
a stoichiometry of 1 mole of nucleotide per mole [12,13]. In
contrast to the antibacterial, polyanion- and DNA-binding
sites, the ATP-binding site is localized in the C-terminal do-
main of LF (between G475 and M604). Binding of ATP by LF
leads to dissociation of its oligomeric forms and to a change
in its interaction with polysaccharides, DNA and proteins.
Here we have demonstrated that LF possesses two DNA-
binding sites for speci¢c and non-speci¢c DNA. The changes
in LF behavior in the presence of ATP and speci¢c DNA, as a
result of dissociation of LF oligomers and/or of allosteric
e¡ects of ATP and DNA on LF interactions with various
ligands, may be very important in the context of its polyfunc-
tional biological activity.
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Fig. 3. Gel retardation analysis of the interaction of LF with ss
[5P-32P]d(pT)10 (lane 1) or ss [5P-32P]d(TAGAAGATCAAA) (lanes
2^8) in di¡erent conditions. LF was incubated with the non-speci¢c
[5P-32P]d(pT)10 (1 WM) or the speci¢c [5P-32P]ON (1 WM) in the ab-
sence of other ligands (lane 2) or in the presence of 0.1 or 1 WM
tRNA (lanes 3 and 4, respectively), 1 or 10 Wg/ml heparin (lines
5 and 6, respectively), 10 WM d(pT)10 (lane 7) or (pU)10 (lane 8).
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